Moderna to provide 500M vaccine doses to Covax

Moderna said May 3 it will supply up to 500 million doses of its COVID-19 vaccine to Covax, the initiative co-led by the World Health Organization to ensure equitable COVID-19 vaccine distribution across the globe.

Advertisement

The first 34 million doses are to be delivered by the end of this year, with the rest to be delivered throughout 2022. 

The deal covers 92 low- and middle-income countries. Moderna, which is based in Massachusetts, said the vaccines would be provided at the “lowest-tiered price,” but didn’t specify what that price is. 

“Covax has now shipped almost 50 million doses of vaccine to 121 countries and economies, but we continue to face serious supply constraints,” Tedros Adhanom Ghebreyesus, PhD, director of the WHO, said at a news conference, The New York Times reported. “Solving this dilemma demands courageous leadership from the world’s largest economies.”

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.